Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meda Lands In U.S. OTC Space With Alaven Buy

This article was originally published in The Tan Sheet

Executive Summary

Meda Pharmaceuticals acquires a larger U.S. presence with an eye on OTC growth, including potential switch candidates
Advertisement

Related Content

Antula Acquisition Expands Meda's OTC Portfolio, Marketing Expertise
Antula Acquisition Expands Meda's OTC Portfolio, Marketing Expertise
Meda Tacks On U.S. Supplements As GSK Cleans Out Medicine Cabinet
Meda Tacks On U.S. Supplements As GSK Cleans Out Medicine Cabinet
International News In Brief
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2010
GSK Expands Consumer Business With Acquisition Of OTC Cold Sore Products
Rx-to-OTC Switch Interest Explodes Following Deal Activity - Experts
Sanofi Eyes Chattem As Key Building Block For Global OTC Growth
Sanofi Eyes Chattem As Key Building Block For Global OTC Growth
Advertisement
UsernamePublicRestriction

Register

PS104473

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel